Company Description
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.
It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.
The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion.
It markets its products primarily with a direct sales force, as well as through agents and resellers.
SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
| Country | United States |
| Founded | 2008 |
| IPO Date | Oct 17, 2018 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 344 |
| CEO | Laura Francis |
Contact Details
Address: 471 El Camino Real, Suite 101 Santa Clara, California 95050 United States | |
| Phone | 408 207 0700 |
| Website | si-bone.com |
Stock Details
| Ticker Symbol | SIBN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001459839 |
| CUSIP Number | 825704109 |
| ISIN Number | US8257041090 |
| Employer ID | 26-2216351 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Laura A. Francis MBA | Chief Executive Officer and Director |
| Anshul Maheshwari | Chief Financial Officer |
| Anthony J. Recupero | President of Commercial Operations |
| Jeff Bertolini | Senior Vice President of Operations and Information Technology |
| Dr. Scott A. Yerby | Senior Vice President of Engineering and Chief Technology Officer |
| Saqib Iqbal | Director of FP&A and Investor Relations |
| Aimee Einstein | Vice President of People and Culture |
| Dr. Daniel Joseph Cher | Senior Vice President of Clinical and Regulatory Affairs |
| Dr. W. Carlton Reckling | Chief Medical Officer and Vice President of Medical Affairs |
| Nikolas F. Kerr | Senior Vice President of Product, Strategy and Business Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 19, 2024 | 144 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 12, 2024 | SCHEDULE 13G | Filing |
| Nov 8, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Oct 3, 2024 | 144 | Filing |
| Sep 3, 2024 | 144 | Filing |
| Aug 19, 2024 | 144 | Filing |